Related references
Note: Only part of the references are listed.Mucosal vaccines - fortifying the frontiers
Ed C. Lavelle et al.
NATURE REVIEWS IMMUNOLOGY (2022)
Nanoparticle-Mediated Delivery of Inhaled Immunotherapeutics for Treating Lung Metastasis
Qiutong Jin et al.
ADVANCED MATERIALS (2021)
Adaptive immunity to SARS-CoV-2 and COVID-19
Alessandro Sette et al.
CELL (2021)
HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV
Aleksandra Milewska et al.
JOURNAL OF VIROLOGY (2021)
Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine
J. Sadoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
IgA dominates the early neutralizing antibody response to SARS-CoV-2
Delphine Sterlin et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19
Carlo Cervia et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Detection of a SARS-CoV-2 variant of concern in South Africa
Houriiyah Tegally et al.
NATURE (2021)
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Pengfei Wang et al.
NATURE (2021)
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Zijun Wang et al.
NATURE (2021)
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
Rita E. Chen et al.
NATURE MEDICINE (2021)
Neutralizing Activity of BNT162b2-Elicited Serum
Yang Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Nicholas G. Davies et al.
SCIENCE (2021)
Underscoring the immense potential of chitosan in fighting a wide spectrum of viruses: A plausible molecule against SARS-CoV-2?
Nivya Sharma et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)
Inhalable nanovaccine with biomimetic coronavirus structure to trigger mucosal immunity of respiratory tract against COVID-19
Bin Zheng et al.
CHEMICAL ENGINEERING JOURNAL (2021)
Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination
Mark M. Painter et al.
IMMUNITY (2021)
Inhalable nanocatchers for SARS-CoV-2 inhibition
Han Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4+ T cell help
Jernej Pusnik et al.
CELL REPORTS (2021)
Intranasal Administration of RBD Nanoparticles Confers Induction of Mucosal and Systemic Immunity against SARS-CoV-2
Tuksin Jearanaiwitayakul et al.
VACCINES (2021)
Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil
Carolina Kymie Vasques Nonaka et al.
EMERGING INFECTIOUS DISEASES (2021)
Oral delivery of metformin by chitosan nanoparticles for polycystic kidney disease
Jonathan Wang et al.
JOURNAL OF CONTROLLED RELEASE (2021)
A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques
Ahmed O. Hassan et al.
CELL REPORTS MEDICINE (2021)
A novel STING agonist for cancer immunotherapy and a SARS-CoV-2 vaccine adjuvant
Jun-Jun Wu et al.
CHEMICAL COMMUNICATIONS (2021)
Agonists and inhibitors of the STING pathway: Potential agents for immunotherapy
Jun-Jun Wu et al.
MEDICINAL RESEARCH REVIEWS (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
Michael Letko et al.
NATURE MICROBIOLOGY (2020)
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Alba Grifoni et al.
CELL (2020)
Manipulation of the Innate Immune Response by Varicella Zoster Virus
Chelsea Gerada et al.
FRONTIERS IN IMMUNOLOGY (2020)
Universal coronavirus vaccines: the time to start is now
Luca T. Giurgea et al.
NPJ VACCINES (2020)
A novel concept for treatment and vaccination against Covid-19 with an inhaled chitosan-coated DNA vaccine encoding a secreted spike protein portion
Dean Tatlow et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2020)
Transmission Routes Analysis of SARS-CoV-2: A Systematic Review and Case Report
Huanjie Li et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Takuya Sekine et al.
CELL (2020)
Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity
Carolyn Rydyznski Moderbacher et al.
CELL (2020)
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
Nina Le Bert et al.
NATURE (2020)
Chemical Strategies to Boost Cancer Vaccines
Wen-Hao Li et al.
CHEMICAL REVIEWS (2020)
Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency
Thamina Acter et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2020)
Intranasal Delivery of a Chitosan-Hydrogel Vaccine Generates Nasal Tissue Resident Memory CD8+ T Cells That Are Protective against Influenza Virus Infection
James G. Bedford et al.
VACCINES (2020)
An inhalable nanoparticulate STING agonist synergizes with radiotherapy to confer long-term control of lung metastases
Yang Liu et al.
NATURE COMMUNICATIONS (2019)
Designable Immune Therapeutical Vaccine System Based on DNA Supramolecular Hydrogels
Yu Shao et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Targeting STING with cyclic di-GMP greatly augmented immune responses of glycopeptide cancer vaccines
Jun-Jun Wu et al.
CHEMICAL COMMUNICATIONS (2018)
The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons
Elizabeth. C. Carroll et al.
IMMUNITY (2016)
Tight junctions: from simple barriers to multifunctional molecular gates
Ceniz Zihni et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
Synthetic Multivalent Glycopeptide-Lipopeptide Antitumor Vaccines: Impact of the Cluster Effect on the Killing of Tumor Cells
Hui Cai et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Variation of the Glycosylation Pattern in MUC1 Glycopeptide BSA Vaccines and Its Influence on the Immune Response
Hui Cai et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
a Totally Synthetic, Self-Assembling, Adjuvant-Free MUC1 Glycopeptide Vaccine for Cancer Therapy
Zhi-Hua Huang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Recent progress in mucosal vaccine development: potential and limitations
Nils Lycke
NATURE REVIEWS IMMUNOLOGY (2012)
Transient Pretreatment With Glucocorticoid Ablates Innate Toxicity of Systemically Delivered Adenoviral Vectors Without Reducing Efficacy
Sergey S. Seregin et al.
MOLECULAR THERAPY (2009)
Randomly 50% N-acetylated low molecular weight chitosan as a novel renal targeting carrier
Zhi-Xiang Yuan et al.
JOURNAL OF DRUG TARGETING (2007)
Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus
RH See et al.
JOURNAL OF GENERAL VIROLOGY (2006)